Neuronetics to Present at the 35th Annual Piper Sandler Healthcare Conference
15 Novembro 2023 - 6:15PM
Neuronetics, Inc. (NASDAQ: STIM), a medical technology company
focused on designing, developing, and marketing products that
improve the quality of life for patients who suffer from
neurohealth disorders, today announced that the management team
will present at the 35th Annual Piper Sandler Healthcare Conference
on Wednesday, November 29, 2023. The Company is scheduled to
present at 2:00 pm Eastern Time the same day via webcast.
A live audio webcast of the presentation will be available
online at the investor relations page of the Company’s website at
ir.neuronetics.com. A replay of the webcast will be archived on the
website for approximately 90 days.
About Neuronetics
Neuronetics, Inc. believes that mental health is as important as
physical health. As a global leader in neuroscience, Neuronetics is
redefining patient and physician expectations with its NeuroStar
Advanced Therapy for Mental Health. NeuroStar is a non-drug,
noninvasive treatment that can improve the quality of life for
people suffering from neurohealth conditions when traditional
medication hasn’t helped. NeuroStar is FDA-cleared for adults with
major depressive disorder (MDD), as an adjunct for adults with
obsessive-compulsive disorder (OCD), and to decrease anxiety
symptoms in adult patients with MDD that may exhibit comorbid
anxiety symptoms (anxious depression). NeuroStar Advanced Therapy
is the leading transcranial magnetic stimulation (TMS) treatment
for MDD in adults with over 5.9 million treatments delivered.
NeuroStar is backed by the largest clinical data set of any TMS
system for depression, including the world’s largest depression
Outcomes Registry. Neuronetics is committed to transforming lives
by offering an exceptional treatment that produces extraordinary
results. For safety and prescribing information, NeuroStar.com.
Investor Contact:
Mike Vallie or Mark KlausnerICR
Westwicke443-213-0499ir@neuronetics.com
Media Contact:
EvolveMKD646-517-4220NeuroStar@evolvemkd.com
Neuronetics (NASDAQ:STIM)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Neuronetics (NASDAQ:STIM)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024